Development and use of an enzyme-linked immunosorbent assay to monitor serum and urine acepromazine concentrations in Thoroghbreds, and possible changes associated with exercise

Chi-Chung Chou From the Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0144.

Search for other papers by Chi-Chung Chou in
Current site
Google Scholar
PubMed
Close
 MS
,
Chao-Ling Chen From the Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0144.

Search for other papers by Chao-Ling Chen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Atwood C. Asbury From the Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0144.

Search for other papers by Atwood C. Asbury in
Current site
Google Scholar
PubMed
Close
 DVM
,
Alistair I. Webb From the Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0144.

Search for other papers by Alistair I. Webb in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
, and
Thomas W. Vickroy From the Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0144.

Search for other papers by Thomas W. Vickroy in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objectives

To develop an ELISA that is sensitive and suitable for measurement of immunoreactive acepromazine (ACP) in horse serum and urine and to determine the acute effects of exercise on immunoreactive ACP values in Thoroughbreds.

Animals

12 healthy Thoroughbreds (5 mares, 5 geldings, 2 stallions), aged 2 to 8 years.

Procedure

A commercially available antibody and a horseradish peroxidase-conjugated oxime derivative of immunoreactive ACP were used to develop a one-step ELISA. Horses were used in a crossover design study to evaluate possible effects of treadmill exercise on serum and urine ACP concentrations after a single (25 mg) IM injection of the drug.

Results

Immunoreactive ACP was detectable at concentrations as low as 50 pg/ml in serum and 100 pg/ml in urine, with intra- and interassay variabilities of 1.1 and 5.2%, respectively. The antibody had some cross-reactivity with a limited number of other phenothiazines. After drug administration, serum ACP immunoreactivity achieved a peak concentration (10.5 ng/ml) within 30 minutes and could be measured up to 48 hours in serum and 120 hours in urine. Although exercise had no significant effect on serum drug concentration, immunoreactive ACP disappeared more quickly (by 48 hours) from the urine of horses in the exercised group.

Conclusions

This one-step ELISA provides a simple and sensitive means to measure immunoreactive ACP in equine serum and urine. The ability to detect drug several days after administration of a low dose of ACP should augment efforts to control illicit use of this drug in performance horses. Potential changes in ACP kinetics after exercise warrant further study. (Am J Vet Res 1998;59:593–597)

Abstract

Objectives

To develop an ELISA that is sensitive and suitable for measurement of immunoreactive acepromazine (ACP) in horse serum and urine and to determine the acute effects of exercise on immunoreactive ACP values in Thoroughbreds.

Animals

12 healthy Thoroughbreds (5 mares, 5 geldings, 2 stallions), aged 2 to 8 years.

Procedure

A commercially available antibody and a horseradish peroxidase-conjugated oxime derivative of immunoreactive ACP were used to develop a one-step ELISA. Horses were used in a crossover design study to evaluate possible effects of treadmill exercise on serum and urine ACP concentrations after a single (25 mg) IM injection of the drug.

Results

Immunoreactive ACP was detectable at concentrations as low as 50 pg/ml in serum and 100 pg/ml in urine, with intra- and interassay variabilities of 1.1 and 5.2%, respectively. The antibody had some cross-reactivity with a limited number of other phenothiazines. After drug administration, serum ACP immunoreactivity achieved a peak concentration (10.5 ng/ml) within 30 minutes and could be measured up to 48 hours in serum and 120 hours in urine. Although exercise had no significant effect on serum drug concentration, immunoreactive ACP disappeared more quickly (by 48 hours) from the urine of horses in the exercised group.

Conclusions

This one-step ELISA provides a simple and sensitive means to measure immunoreactive ACP in equine serum and urine. The ability to detect drug several days after administration of a low dose of ACP should augment efforts to control illicit use of this drug in performance horses. Potential changes in ACP kinetics after exercise warrant further study. (Am J Vet Res 1998;59:593–597)

Advertisement